Skip to content

Protagenic Therapeutics, Inc.\new: filings

Every Protagenic Therapeutics, Inc.\new annual and quarterly report in the SEC record with the published financial measures it tagged, 53 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-19fiscal Q1 202636720001493152-26-039221
10-K2026-08-14fiscal FY 202638690001493152-26-038255
10-Q2026-03-09fiscal Q3 2026381060001493152-26-009301
10-Q2025-11-26fiscal Q2 2026391030001493152-25-025201
10-Q2025-05-13fiscal Q1 202528560001641172-25-009923
10-K2025-03-31fiscal FY 202429570001641172-25-001600
10-Q2024-11-14fiscal Q3 202429950001493152-24-045913
10-Q2024-08-14fiscal Q2 202429910001493152-24-032349
10-Q2024-05-15fiscal Q1 202428570001493152-24-019933
10-K/A2024-05-14fiscal FY 202328570001493152-24-019018
10-K/A2024-04-24fiscal FY 202328570001493152-24-015739
10-K2024-04-01fiscal FY 202328570001493152-24-012333
10-Q2023-11-14fiscal Q3 202328930001493152-23-041032
10-Q2023-08-14fiscal Q2 202328890001493152-23-028345
10-Q2023-05-15fiscal Q1 202326530001493152-23-017171
10-K2023-03-31fiscal FY 202228540001493152-23-010152
10-Q2022-11-14fiscal Q3 202225800001493152-22-031862
10-Q2022-08-11fiscal Q2 202225760001493152-22-022069
10-Q2022-05-13fiscal Q1 202225500001493152-22-013159
10-K2022-04-07fiscal FY 202125490001493152-22-009370
10-Q2021-11-15fiscal Q3 202124740001493152-21-028641
10-Q2021-08-16fiscal Q2 202122650001493152-21-020241
10-Q2021-05-17fiscal Q1 202122450001493152-21-011799
10-K2021-03-25fiscal FY 202024470001493152-21-006756
10-Q2020-11-16fiscal Q3 202024720001493152-20-021645
10-Q2020-08-14fiscal Q2 202024680001493152-20-015885
10-Q2020-06-18fiscal Q1 202024480001493152-20-011408
10-K2020-04-29fiscal FY 201924480001493152-20-007286
10-Q2019-11-14fiscal Q3 201922700001493152-19-017362
10-Q2019-08-14fiscal Q2 201922660001493152-19-012595
10-Q2019-05-16fiscal Q1 201922480001493152-19-007634
10-K2019-03-29fiscal FY 201822460001493152-19-004288
10-Q2018-11-08fiscal Q3 201822620001493152-18-015449
10-Q2018-08-14fiscal Q2 201822620001493152-18-011762
10-Q2018-05-15fiscal Q1 201821430001493152-18-006888
10-K2018-04-02fiscal FY 201723450001493152-18-004567
10-Q2017-11-13fiscal Q3 201724630001437749-17-019116
10-Q2017-08-08fiscal Q2 201721600001437749-17-014027
10-Q2017-05-15fiscal Q1 201721430001437749-17-009213
10-K/A2017-05-08fiscal FY 201624490001437749-17-008187
10-K2017-04-18fiscal FY 201624490001437749-17-006686
10-Q2016-11-17fiscal Q3 201623590001437749-16-042353
10-Q2016-08-15fiscal Q2 201623590001437749-16-037450
10-Q2016-07-25fiscal Q1 201625480001437749-16-035574
10-Q2016-03-11fiscal Q2 201618520001193125-16-501639
10-Q2015-11-13fiscal Q1 201618380001144204-15-065330
10-K2015-09-25fiscal FY 201527560001144204-15-056587
10-Q2015-05-11fiscal Q3 201527820001144204-15-029454
10-Q2015-02-06fiscal Q2 201527820001144204-15-006780
10-Q2014-11-13fiscal Q1 201527560001144204-14-067723
10-K2014-10-14fiscal FY 201431350001144204-14-060987
10-Q2011-11-14fiscal Q3 201137960001144204-11-064110
10-Q/A2011-09-07fiscal Q2 2011391000001144204-11-051575

Inspect the source

Entity
Protagenic Therapeutics, Inc.\new / CIK 0001022899
Captured
2026-09-20T05:13:45.961Z
SEC response SHA-256
65b45c5addd26cd3e105dbeb1582537b1352dc73c447a8d926c77d81587fc033

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001022899.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))